Description
A DNA topoisomerase I inhibitor; exhibits selective cytotoxicity across a panel of 46 NSCLC lines (IC50s = ~2 μM for HCC4017, H292, and H1819 cells versus >20 μM for the remaining cell lines); induces cleavage of PARP and caspase-3 and blocks DNA replication, RNA transcription, and protein translation in susceptible-, but not resistant-, cells in a dose-dependent manner; inhibits the ability of recombinant topoisomerase 1 to relax supercoiled DNA; topoisomerase 1 knockdown rescues HCC4017 cells from SW04428 cytotoxicity; expression of CDKN1A reduces SW044248 cytotoxicity
Formal name: 2-[(5-ethyl-5H-1,2,4-triazino[5,6-b]indol-3-yl)thio]-N-(2-methoxyphenyl)-butanamide
Synonyms:
Molecular weight: 421.5
CAS: 522650-83-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Topoisomerases||Research Area|Cancer|Cell Death||Research Area|Cancer|DNA Damage and Repair